CDSCO UID MFG/IVD/2019/000026_8892ed2405ab50d5528c3deb2420ae64_a193dc50f7bd8a946329d4a12f383058
HUMAN IMMUNODEFICIENCY RAPID TEST
Nucleus Diagnosys LLP·Device Class Class D·India CDSCO·Brand: HIV 1&2
Registration details
- UID
- MFG/IVD/2019/000026_8892ed2405ab50d5528c3deb2420ae64_a193dc50f7bd8a946329d4a12f383058
- Device class
- Class D
- Brand name
- HIV 1&2
- License holder
- Nucleus Diagnosys LLP
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- Nuvision HIV 1&2 Rapid Test is a rapid immunochromatographic assay for the qualitative detection of antibodies against HIV 1 & 2 in human Whole Blood, Serum or Plasma samples. It is intended for professional use as a tool in the diagnosis of HIV infection
Similar products (3)
Other products with the same name or brand
Covid-19 Rapid Antigen Test-COVID-19 Antigen Test is a rapid and convenient immunochromatographic assay for the qualitative detection of COVID-19 antigen from nasopharyngeal/nasal swab obtained from patient with signs and symptoms of respiratory infection. This test is for administration by healthcare workers and labs only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms of SARS-CoV-2 infection. It provides only an initial screening test result. This product is strictly for medical professional use only and not intended for personal use. The result of this test should not be the sole basis for the diagnosis and the test results should be confirmed by Real-Time Reverse Transcriptase
Brand: HIV 1&2
Nucleus Diagnosys LLP
Class D
Diagnostics test reagent/Kit for Hepatitis B Virus Surface Antigen
Brand: HIV 1&2
Nucleus Diagnosys LLP
Class D
Diagnostic test for Hepatitis C Virus Rapid Test
Brand: HIV 1&2
Nucleus Diagnosys LLP
Class D
Other products from Nucleus Diagnosys LLP
Products from the same license holder (10 products)
Diagnostics test reagent/ kits for RF, ASO and CRP Control
Class C
Covid-19 Rapid Antigen Test-COVID-19 Antigen Test is a rapid and convenient immunochromatographic assay for the qualitative detection of COVID-19 antigen from nasopharyngeal/nasal swab obtained from patient with signs and symptoms of respiratory infection. This test is for administration by healthcare workers and labs only, as an aid to early diagnosis of SARS-CoV-2 infection in patient with clinical symptoms of SARS-CoV-2 infection. It provides only an initial screening test result. This product is strictly for medical professional use only and not intended for personal use. The result of this test should not be the sole basis for the diagnosis and the test results should be confirmed by Real-Time Reverse Transcriptase
Brand: HIV 1&2
Class D
Diagnostic tests/Reagents/kits for monitoring Phencyclidine drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Barbiturates drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Methaqualone drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Tricycilic Antidepressants drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Propoxyphene drug levels used for therapy or abuse.
Class C
Diagnostic tests/Reagents/kits for monitoring Methamphetamine drug levels used for therapy or abuse
Class C
Diagnostics test reagent/ kits for Troponin I
Brand: TRA
Class C
Diagnostics Test for Syphilis Rapid Test
Class D
About this record
HUMAN IMMUNODEFICIENCY RAPID TEST is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2019/000026_8892ed2405ab50d5528c3deb2420ae64_a193dc50f7bd8a946329d4a12f383058. This device is marketed under the brand name HIV 1&2. The license holder is Nucleus Diagnosys LLP, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.